MX346345B - Composiciones que comprenden galatos y galamidas. - Google Patents

Composiciones que comprenden galatos y galamidas.

Info

Publication number
MX346345B
MX346345B MX2014007533A MX2014007533A MX346345B MX 346345 B MX346345 B MX 346345B MX 2014007533 A MX2014007533 A MX 2014007533A MX 2014007533 A MX2014007533 A MX 2014007533A MX 346345 B MX346345 B MX 346345B
Authority
MX
Mexico
Prior art keywords
compositions
trihydroxyphenyl
formula
gallamides
gallates
Prior art date
Application number
MX2014007533A
Other languages
English (en)
Other versions
MX2014007533A (es
Inventor
Xu Guofeng
Miller Steven
Jaracz Stanislav
Leigh Leonora
Picquet Guillaume
Du-Thumm Laurence
Original Assignee
Colgate Palmolive Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Colgate Palmolive Co filed Critical Colgate Palmolive Co
Publication of MX2014007533A publication Critical patent/MX2014007533A/es
Publication of MX346345B publication Critical patent/MX346345B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37—Esters of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37—Esters of carboxylic acids
    • A61K8/375—Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/42—Amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/42—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/44—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring
    • C07C235/54—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/76—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring
    • C07C69/84—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring of monocyclic hydroxy carboxylic acids, the hydroxy groups and the carboxyl groups of which are bound to carbon atoms of a six-membered aromatic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/005—Antimicrobial preparations
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane

Abstract

Se describen composiciones para uso tópico que comprenden una concentración eficaz como bactericida de un compuesto de galato o galamida, que es un cicloalquilo o heterocicloalquilo polisustituido, en donde los sustituyentes se seleccionan del grupo que consiste en hidroxilo, hidroximetilo, fluoro, cloro, amino, nitro o un grupo de fórmula -X-(CO)-(3,4,5-trihidroxifenilo ), en donde X se selecciona entre O y NR, con la condición de que los sustituyentes comprendan al menos dos grupos de fórmula -X(CO)-(3,4,5-trihidroxifenilo) unidos a carbonos adyacentes en forma de sal libre o aceptable para aplicación oral o tópica, así como también métodos para elaborar y usar las mismas.
MX2014007533A 2011-12-21 2012-12-17 Composiciones que comprenden galatos y galamidas. MX346345B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13/333,209 US20130164228A1 (en) 2011-12-21 2011-12-21 Compositions comprising gallates and gallamides
PCT/US2012/070062 WO2013096182A2 (en) 2011-12-21 2012-12-17 Compositions comprising gallates and gallamides

Publications (2)

Publication Number Publication Date
MX2014007533A MX2014007533A (es) 2014-08-27
MX346345B true MX346345B (es) 2017-03-14

Family

ID=47522925

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2014007533A MX346345B (es) 2011-12-21 2012-12-17 Composiciones que comprenden galatos y galamidas.

Country Status (16)

Country Link
US (1) US20130164228A1 (es)
EP (1) EP2794030B1 (es)
JP (1) JP2015503520A (es)
CN (1) CN105592892B (es)
AR (1) AR089390A1 (es)
AU (1) AU2012355482B2 (es)
BR (1) BR112014015259A2 (es)
CA (1) CA2859211A1 (es)
CO (1) CO6990720A2 (es)
MX (1) MX346345B (es)
PH (1) PH12014501303A1 (es)
RU (1) RU2014129876A (es)
SG (1) SG11201402929YA (es)
TW (1) TW201338796A (es)
WO (1) WO2013096182A2 (es)
ZA (1) ZA201404283B (es)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE112008001301T5 (de) 2007-05-14 2010-04-29 Reserach Foundation Of State University Of New York Induktion einer physiologischen Dispersions-Antwort in Bakterien-Zellen in einem Biofilm
US20150099010A1 (en) 2013-10-07 2015-04-09 Reoxcyn Discoveries Group, Inc Redox signaling gel formulation
US9662276B2 (en) * 2015-06-16 2017-05-30 President And Fellows Of Harvard College Methodology of dental caries detection
US20170202877A1 (en) 2016-01-19 2017-07-20 Reoxcyn Discoveries Group, Inc. Hypochlorite formulations for wound healing
US11857674B2 (en) 2016-05-18 2024-01-02 Reoxcyn, Llc Lubricant formulations
US9474768B1 (en) 2016-05-18 2016-10-25 Reoxcyn Discoveries Group, Inc. Lubricant formulations
CN106310236A (zh) * 2016-08-29 2017-01-11 陈石良 一种抗氧化sod口腔喷雾剂及其制备方法
US9833471B1 (en) 2016-09-15 2017-12-05 Reoxcyn Discoveries Group, Inc. Hypochlorous acid-based hand sanitizer
CN110022944A (zh) 2016-10-20 2019-07-16 高露洁-棕榄公司 用于口腔护理或清洁的抗微生物组合物，以及用于抗附着聚合物和涂层的方法
US20180200165A1 (en) 2017-01-16 2018-07-19 Reoxcyn Innovation Group, Llc Dentifrice formulations and methods of oral care
CN107224444A (zh) * 2017-06-14 2017-10-03 新疆奇康哈博维医药研究院（有限公司） 一种西帕依固龈药物及其在制备治疗痤疮药物中的应用
CN107468587B (zh) * 2017-09-14 2020-09-22 好维股份有限公司 一种包含稳定多酚的口腔护理组合物
CN108456148B (zh) * 2018-05-09 2020-09-25 陕西理工大学 N-(3,4,5-三羟基苯甲酰)-3,4,5-三羟基苯甲酰胺及其制备方法与应用
US10927138B2 (en) * 2018-05-29 2021-02-23 Syneurx International (Taiwan) Corp. Inhibitors of D-amino acid oxidase (DAAO) and uses thereof
US11541105B2 (en) 2018-06-01 2023-01-03 The Research Foundation For The State University Of New York Compositions and methods for disrupting biofilm formation and maintenance
US11047700B2 (en) 2019-02-01 2021-06-29 Uber Technologies, Inc. Navigation and routing based on image data
US11154531B2 (en) 2020-02-08 2021-10-26 Syneurx International (Taiwan) Corp. Compounds and pharmaceutical uses thereof
CN111329875B (zh) * 2020-02-26 2023-07-21 好维股份有限公司 用于修复口腔软组织细胞的口腔护理组合物及应用
KR20230004765A (ko) 2020-04-23 2023-01-06 신유알엑스 인터내셔널 (타이완) 코포레이션 화합물 및 이의 약학적 용도
KR20220157691A (ko) * 2021-05-21 2022-11-29 김드보라 레몬즙에 크림제형을 혼합한 동물 링웜 혼합크림 및 제조방법

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030105027A1 (en) * 2001-11-06 2003-06-05 Rosenbloom Richard A. Nutritional supplements and methods for prevention, reduction and treatment of radiation injury
JP2005213194A (ja) * 2004-01-29 2005-08-11 Mitsui Chemicals Inc ポリフェノール類を含有する抗菌剤
CN101123944A (zh) * 2004-12-23 2008-02-13 高露洁-棕榄公司 含有未氧化山茶提取物的口腔护理组合物
US7399783B2 (en) * 2005-06-22 2008-07-15 The Quigley Corporation Methods for the treatment of scar tissue
CA2662083C (en) * 2006-08-28 2016-09-20 Omnio Healer Ab Novel drug target of preventing and treating periodontal disease, improving healing of periodontal wounds and promoting oral health
WO2008131047A2 (en) * 2007-04-16 2008-10-30 The Regents Of The University Of Michigan Plasminogen activator inhibitor-1 inhibitors and methods of use thereof to modulate lipid metabolism
JP2012505855A (ja) * 2008-10-17 2012-03-08 ユニヴェルシテ リブレ ド ブリュッセル 抗癌治療における使用のためのジバニロイルおよびトリバニロイル誘導体
WO2010106545A1 (en) * 2009-03-16 2010-09-23 Cavinkare Pvt. Ltd. Skin care agent and compositions thereof
CA2758967A1 (en) * 2009-04-16 2010-10-21 Forsyth Dental Infirmary For Children New methods of making an antibody and compositions thereof
TWI415572B (zh) * 2011-06-17 2013-11-21 Univ Chang Gung 利用１，２，３，４，６－五－ｏ－沒食子醯基－ｄ－葡哌喃糖來抑制生物膜形成

Also Published As

Publication number Publication date
ZA201404283B (en) 2016-03-30
CN105592892B (zh) 2020-04-10
PH12014501303A1 (en) 2014-09-15
AU2012355482B2 (en) 2014-10-09
WO2013096182A3 (en) 2014-04-10
AR089390A1 (es) 2014-08-20
RU2014129876A (ru) 2016-02-10
US20130164228A1 (en) 2013-06-27
BR112014015259A8 (pt) 2017-06-13
CO6990720A2 (es) 2014-07-10
SG11201402929YA (en) 2014-07-30
AU2012355482A1 (en) 2014-06-19
CA2859211A1 (en) 2013-06-27
CN105592892A (zh) 2016-05-18
TW201338796A (zh) 2013-10-01
MX2014007533A (es) 2014-08-27
EP2794030A2 (en) 2014-10-29
JP2015503520A (ja) 2015-02-02
WO2013096182A2 (en) 2013-06-27
BR112014015259A2 (pt) 2017-06-13
EP2794030B1 (en) 2017-03-15

Similar Documents

Publication Publication Date Title
PH12014501303A1 (en) Compositions comprising gallates and gallamides
MX2018001990A (es) Composiciones que comprenden un inhibidor de p13k y un inhibidor de hdac.
EA201490418A1 (ru) Новые макроциклические соединения в качестве ингибиторов фактора xia
EA201590277A1 (ru) Дигидропиридон р1 в качестве ингибиторов фактора xia
GEP201606555B (en) Compounds and compositions for modulating egfr activity
MX2012008874A (es) Macrociclos como inhibidores del factor de coagulacion (fxia).
MY164776A (en) Heterocyclic compound
MY148253A (en) Azaadamantane derivatives and methods of use
TN2012000063A1 (en) Quinazolines as potassium ion channel inhibitors
UA112534C2 (uk) Похідні гетероарилпіперидину, проміжні сполуки, композиція для боротьби із шкідливими фітопатогенними грибами та спосіб її виготовлення
TN2014000016A1 (en) 4 - piperidinyl compounds for use as tankyrase inhibitors
TW200800951A (en) Substituted imidazole compounds as KSP inhibitors
WO2013177534A3 (en) New salicylic acid derivatives, pharmaceutically acceptable salt thereof, composition thereof and method of use thereof
CA2817362C (en) Lipoyl compounds and their use for treating ischemic injury
EP2585455A4 (en) COMPOUNDS AND THEIR USE IN THE MODULATION OF THE CONCENTRATIONS OF VARIOUS AMYLOID BETA PEPTIDE ALLOYS
NZ700356A (en) Pyrazole compounds as sglt1 inhibitors
MX2016003566A (es) Composicion que contiene polietilen glicol.
EA201000616A1 (ru) Фунгицидные соединения, способ их получения и их применение для борьбы с вредными грибами, а также содержащие их средства
PH12015501146A1 (en) Hydantoin derivative
EA201391586A1 (ru) ИНГИБИТОРЫ 17α-ГИДРОКСИЛАЗЫ/C-ЛИАЗЫ
SG195136A1 (en) Trpv1 antagonists including dihydroxy substituent and uses thereof
PH12014502747A1 (en) Phosphoramidic acid prodrugs of 5 - [5 - phenyl- 4 - (pyridin- 2 - ylmethylamino) quinazolin- 2 - yl] pyridine- 3 - sulfonamide
MX2012007837A (es) Derivados de oxazolopirimidina 2, 5 - sustituidos.
MX2013009386A (es) Nuevos compuestos de azaespirodecanona.
MY162945A (en) Azole derivative

Legal Events

Date Code Title Description
FG Grant or registration